These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34766615)

  • 1. Surface specifically modified NK-92 cells with CD56 antibody conjugated superparamagnetic Fe
    Zhao S; Duan J; Lou Y; Gao R; Yang S; Wang P; Wang C; Han L; Li M; Ma C; Liang X; Liu H; Sang Y; Gao L
    Nanoscale; 2021 Nov; 13(45):19109-19122. PubMed ID: 34766615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic delivery of Fe
    Wu L; Zhang F; Wei Z; Li X; Zhao H; Lv H; Ge R; Ma H; Zhang H; Yang B; Li J; Jiang J
    Biomater Sci; 2018 Sep; 6(10):2714-2725. PubMed ID: 30151523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell membrane-encapsulated magnetic nanoparticles for enhancing natural killer cell-mediated cancer immunotherapy.
    Wu D; Shou X; Zhang Y; Li Z; Wu G; Wu D; Wu J; Shi S; Wang S
    Nanomedicine; 2021 Feb; 32():102333. PubMed ID: 33188908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK-92 cells labeled with Fe
    Lian J; Li M; Duan M; Sun Y; Wang Z; Guo X; Li J; Gao G; Li K
    J Nanobiotechnology; 2024 Jun; 22(1):313. PubMed ID: 38840120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dual-functional capability of cytokine-induced killer cells and application in tumor immunology.
    Zhang Q; Liu XY; Zhang T; Zhang XF; Zhao L; Long F; Liu ZK; Wang EH
    Hum Immunol; 2015 May; 76(5):385-91. PubMed ID: 25305457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging.
    Daldrup-Link HE; Meier R; Rudelius M; Piontek G; Piert M; Metz S; Settles M; Uherek C; Wels W; Schlegel J; Rummeny EJ
    Eur Radiol; 2005 Jan; 15(1):4-13. PubMed ID: 15616814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Engineered Natural Killer Cells Combined with Antiheat Endurance as a Powerful Strategy for Enhancing Photothermal-Immunotherapy Efficiency of Solid Tumors.
    Zhang D; Zheng Y; Lin Z; Lan S; Zhang X; Zheng A; Li J; Liu G; Yang H; Liu X; Liu J
    Small; 2019 Oct; 15(42):e1902636. PubMed ID: 31468667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered nanoparticles to enhance natural killer cell activity towards onco-immunotherapy: a review.
    Phung CD; Tran TH; Kim JO
    Arch Pharm Res; 2020 Jan; 43(1):32-45. PubMed ID: 31993969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and metabolic targeting of natural killer cells to solid tumors.
    Wang J; Matosevic S
    Cell Oncol (Dordr); 2020 Aug; 43(4):577-600. PubMed ID: 32488848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic-Manipulated NK Cell Proliferation and Activation Enhance Immunotherapy of Orthotopic Liver Cancer.
    Jiang H; Fu H; Min T; Hu P; Shi J
    J Am Chem Soc; 2023 Jun; 145(24):13147-13160. PubMed ID: 37262421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies.
    Matosevic S
    J Immunol Res; 2018; 2018():4054815. PubMed ID: 30306093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanded CD56
    Poznanski SM; Nham T; Chew MV; Lee AJ; Hammill JA; Fan IY; Butcher M; Bramson JL; Lee DA; Hirte HW; Ashkar AA
    Cancer Immunol Res; 2018 Oct; 6(10):1174-1185. PubMed ID: 30018043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56
    Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
    Front Immunol; 2019; 10():14. PubMed ID: 30761123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes.
    Ji T; Lang J; Ning B; Qi F; Wang H; Zhang Y; Zhao R; Yang X; Zhang L; Li W; Shi X; Qin Z; Zhao Y; Nie G
    Adv Mater; 2019 Feb; 31(6):e1804395. PubMed ID: 30549110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered Three-Dimensional Tumor Models to Study Natural Killer Cell Suppression.
    Temples MN; Adjei IM; Nimocks PM; Djeu J; Sharma B
    ACS Biomater Sci Eng; 2020 Jul; 6(7):4179-4199. PubMed ID: 33463353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors.
    Sim T; Choi B; Kwon SW; Kim KS; Choi H; Ross A; Kim DH
    ACS Nano; 2021 Aug; 15(8):12780-12793. PubMed ID: 34165964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing Magnetically Responsive Biohybrids Composed of Cord Blood-Derived Natural Killer Cells and Iron Oxide Nanoparticles.
    Burga RA; Khan DH; Agrawal N; Bollard CM; Fernandes R
    Bioconjug Chem; 2019 Mar; 30(3):552-560. PubMed ID: 30779553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Natural Killer Cells for Tumor Immunotherapy.
    Zhang C; Hu Y; Shi C
    Front Immunol; 2020; 11():60. PubMed ID: 32140153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy.
    Kim KS; Han JH; Choi SH; Jung HY; Park JD; An HJ; Kim SE; Kim DH; Doh J; Han DK; Kim IH; Park W; Park KS
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56731-56740. PubMed ID: 33290037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors.
    Nayyar G; Chu Y; Cairo MS
    Front Oncol; 2019; 9():51. PubMed ID: 30805309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.